Urinary Retention

Updated: August 28, 2022

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

bethanechol

10 - 50

Orally

once a day

or divided 3-4 times a day
Take 2 hours after meals or 1 hour before meals

bethanechol

10 - 50

Orally 

thrice a day

50-100 mg orally twice a day may be needed for certain patients
Take 1 hour before the meals or 2 hours later the meal

neostigmine

For Prevention:
Administer dose of 0.25 mg intramuscularly once surgery completed
Repeat this every 4 to 6 hours for next 2 to 3 days
For Treatment:
Administer dose of 0.5 to 1 mg intramuscularly and up to every 3 hours as needed
Administration
Intravenous train-of-four monitoring for Neuromuscular Blockade reversal:
Peripheral nerve stimulation devices capable of producing a train-of-four stimulus are required to effectively and safely regulate intravenous dose

bethanechol

Off-label: 0.3-0.6 mg/kg orally once a day or divided 3-4 times a day
Take 2 hours after meals or 1 hour before meals

bethanechol

0.3 to 0.6 mg/kg/day orally every 6 to 8 hours
Take 1 hour before the meals or 2 hours later the meal

Future Trends